Pharmacist impact on diabetes disease By: Antria Pavlidou (Ph.D. Candidate, UCL, MSc Clinical Pharmacy, International Practice and Policy, UCL) Over the past 20 years, the number of adults living with diabetes has more than tripled. According to the International Diabetes Federation (IDF), in 2021, approximately 537 million people, or 10.5% of the world’s population (20–79…

Introducing ISPPA — the International Social Prescribing Pharmacy Association By: Arun Nadarasa, Jenny Kirschner, Maria Halimeh, Tarek Hussain, Islam Omar, Xavier Schneider, Capitán Adsuar, Yogendra Kanchapu, Gonzalo Miguel Adsuar Meseguer, and Adam Pattison Rathbone. What is social prescribing? Social prescribing is already a key part of everyday community pharmacy practice. Social prescribing includes identifying patients who may be experiencing poor mental and physical…

CHALLENGES TO THE AVAILABILITY OF NEW MEDICINES IN LOW AND MIDDLE-INCOME COUNTRIES By: Onyeka Obidiegwu, M.Pharm (New Medicines SIG Liaison) Medicine availability is a long-standing issue that cannot be overstated because a drug is only useful when it is available to address the specific issues for which it was designed. The cost of medicines is a big problem in low- and middle-income…

Monkeypox — a global health issue after COVID-19 By: Sherilyn Wong Just as we started to see the light at the end of the tunnel that was the COVID-19 pandemic, on July 23, 2022, the World Health Organization declared the growing monkeypox outbreak a global health emergency of international concern. (1) As of 19 September 2022, over 64,000…

(FIP Patient Safety Development Goal 19) By: Rafa Al Khalifa “MEDICATION WITHOUT HARM” serves as a reminder to all parties involved that the end user, or “the patient,” is who matters most when it comes to safety. In May 2019, the WHO announced the 17th of September as the annual…

Prof. Dr. Madeeha Malik Hello Madeeha, Thank you for agreeing to do this interview. Can you tell us a bit about yourself and your career? Hello! I am Prof. Dr. Madeeha Malik, a healthcare service entrepreneur, researcher, trainer, community builder, pharmacist, academician, and advocate of gender equity. I did my…

Name: Dr. Didier Mouliom Ngambe Country: Cameroon Current Job Position: Shareholder of Ubipharm, Board Consultant in business development and Human Resource recruitment, Ubipharm is a 1 Billion USD company, distributor of drugs in Africa and French DomTom and manufacturer of generic drugs Ubigen. Vice President of IPS / FIP Industrial…

Name: Igor Linhares de Castro Country: Brazil Current Job Position: RA Director, Deputy Country Head, Brazil/LATAM, BIOCAD Area of Expertise: Regulatory Affairs Current Role in the SIG/Section: Secretary, Industrial Pharmacy Section (IPS) Describe your experience in the SIG/Section: I became a member of FIP/IPS in 2010. In the same year…

By: Rafa Al Khalifa “Planning is bringing the future into the present so that you can do something about it now.”- Alan Lakein. In 2020, FIP has planned and set its Development Goals (DGs) with the aim to transform the future of pharmacy practice. These 21 FIP DGs, far-sighted, aim…